Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001179110-20-010602

Director sold 27,000 shares at an average $51.54 ($1,391,544)

  • Director acquired 27,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SOUTHWELL DAVID P · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2020-10-16 Exercise or conversion : show line 1 in the form +15,000 $10.85 $162,750 16,650 D
2020-10-16 Sale : show line 2 in the form −14,300 $51.50 $736,493 2,350 D
2020-10-16 Sale : show line 3 in the form −700 $52.18 $36,528 1,650 D
2020-10-16 Exercise or conversion : show line 4 in the form +12,000 $11.23 $134,760 13,650 D
2020-10-16 Sale : show line 5 in the form −11,500 $51.52 $592,434 2,150 D
2020-10-16 Sale : show line 6 in the form −500 $52.18 $26,089 1,650 D
Open-market sales · 27,000 sh · avg $51.54 · $1,391,544

Table II: Derivative

2 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2020-10-16 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −15,000 $10.85 $162,750 $10.85 2023-05-15 15,000 0 D
2020-10-16 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −12,000 $11.23 $134,760 $11.23 2027-01-02 12,000 0 D
Loading xslF345X03/edgar.xml…